Newsroom
Amgen presents abstract validating use of AI and advanced data sources for asthma at CHEST
Using artificial intelligence applied to the entire patient record resulted in a 56% absolute increase and 165% relative increase in accuracy in identifying patients with severe asthma compared to a traditional, structured data-only approach. This high-validity approach was also able to identify disease subtypes such as eosinophilic asthma. Differences in accuracy between the two approaches were particularly pronounced for symptoms, findings, and procedures, with a 54% – 99% absolute increase and 131% – 2162% relative increase in accuracy for the high-validity approach.
Read at the original outletAll news